Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-016599
Filing Date
2025-06-11
Accepted
2025-06-11 07:30:07
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 form4a-06112025_070604.html 4/A  
1 form4a-06112025_070604.xml 4/A 3947
  Complete submission text file 0001415889-25-016599.txt   5347
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39264 | Film No.: 251038776

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)